Followers | 504 |
Posts | 10140 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Saturday, December 05, 2015 12:17:02 PM
bullish 14.12
moving average support
## source: finance.yahoo.com
Fri, 04 Dec 2015 14:50:32 GMT ~ TG Therapeutics, Inc. Recaps Schedule of Data Presentations at the 57th American Society of Hematology Annual Meeting
[at noodls] - TG Therapeutics, Inc. Recaps Schedule of Data Presentations at the 57th American Society of Hematology Annual Meeting
read full: http://www.noodls.com/view/16ED4D49615664DC54F9D3E231F861E715096686
*********************************************************
Fri, 04 Dec 2015 14:30:00 GMT ~ TG Therapeutics, Inc. Recaps Schedule of Data Presentations at the 57th American Society of Hematology Annual Meeting
[GlobeNewswire] - ORLANDO, Fla., Dec. 04, 2015-- TG Therapeutics, Inc. today recapped the schedule of data presentations for their lead compounds at the upcoming 57 th American Society of Hematology Annual Meeting, to be ...
read full: http://finance.yahoo.com/news/tg-therapeutics-inc-recaps-schedule-143000726.html
*********************************************************
Tue, 17 Nov 2015 18:04:34 GMT ~ TG THERAPEUTICS, INC. Financials
read full: http://finance.yahoo.com/q/is?s=tgtx
*********************************************************
Mon, 09 Nov 2015 14:05:54 GMT ~ TG Therapeutics reports 3Q loss
read full: http://sg.finance.yahoo.com/news/tg-therapeutics-reports-3q-loss-140554981.html
*********************************************************
Mon, 09 Nov 2015 14:05:54 GMT ~ TG Therapeutics reports 3Q loss
read full: http://finance.yahoo.com/news/tg-therapeutics-reports-3q-loss-140554732.html
*********************************************************
$TGTX charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$TGTX company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/TGTX/company-info
Ticker: $TGTX
OTC Market Place: Not Available
CIK code: 0001001316
Company name: TG Therapeutics, Inc.
Company website: http://www.manhattanpharma.com
Incorporated In: DE, USA
Business Description:
$TGTX share structure
## source: otcmarkets.com
Market Value: $741,577,966 a/o Dec 04, 2015
Shares Outstanding: 52,519,686 a/o Nov 06, 2015
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.001
$TGTX extra dd links
Company name: TG Therapeutics, Inc.
Company website: http://www.manhattanpharma.com
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/TGTX/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/TGTX/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=TGTX+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=TGTX+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=TGTX+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/TGTX/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/TGTX/news - http://finance.yahoo.com/q/h?s=TGTX+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/TGTX/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/TGTX/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/TGTX/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/TGTX/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/TGTX/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/TGTX/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/TGTX/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/TGTX/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=TGTX+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/TGTX
DTCC (dtcc.com): http://search2.dtcc.com/?q=TG+Therapeutics%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=TG+Therapeutics%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=TG+Therapeutics%2C+Inc.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.manhattanpharma.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.manhattanpharma.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.manhattanpharma.com
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/TGTX/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/TGTX
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/TGTX/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/TGTX/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/TGTX/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001001316&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/TGTX/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/TGTX/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/TGTX/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/TGTX/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=TGTX&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=TGTX
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/TGTX/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=TGTX+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=TGTX+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=TGTX
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=TGTX
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=TGTX+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/TGTX/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=TGTX+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/TGTX.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=TGTX
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/TGTX/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/TGTX/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/TGTX/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/TGTX/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/TGTX
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/TGTX
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/TGTX:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=TGTX
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=TGTX
$TGTX DD Notes ~ http://www.ddnotesmaker.com/TGTX
Recent TGTX News
- New BRIUMVI® (ublituximab-xiiy) Data from the ENHANCE Phase 3b Study Show Rapid 30-Minute Infusions are Well Tolerated in Patients with Relapsing Forms of Multiple Sclerosis • GlobeNewswire Inc. • 09/18/2024 11:15:00 AM
- New Data for BRIUMVI® (ublituximab-xiiy) Demonstrate that 92% of Patients with Relapsing Multiple Sclerosis Were Free from Disability Progression After 5 Years of Treatment • GlobeNewswire Inc. • 09/18/2024 11:00:00 AM
- Palantir Technologies, Dell Technologies, and Erie Indemnity Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 • PR Newswire (US) • 09/06/2024 10:43:00 PM
- TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI at the 2024 European Committee for Treatment and Research in Multiple Sclerosis Annual Meeting • GlobeNewswire Inc. • 09/05/2024 11:30:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2024 08:03:55 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 08/09/2024 08:01:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2024 11:08:39 AM
- TG Therapeutics Reports Second Quarter 2024 Financial Results and Raises BRIUMVI® (ublituximab-xiiy) Full Year Revenue Guidance • GlobeNewswire Inc. • 08/06/2024 11:00:00 AM
- TG Therapeutics to Host Conference Call on Second Quarter 2024 Financial Results and Business Update • GlobeNewswire Inc. • 08/05/2024 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/17/2024 08:48:08 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/17/2024 07:08:53 PM
- Form PX14A6G - Notice of exempt solicitation submitted by non-management • Edgar (US Regulatory) • 06/10/2024 03:23:35 PM
- TG Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference • GlobeNewswire Inc. • 06/07/2024 11:50:00 AM
- TG Therapeutics to Participate in the Jefferies Global Healthcare Conference • GlobeNewswire Inc. • 06/03/2024 11:30:00 AM
- TG Therapeutics Announces Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the 2024 Consortium of Multiple Sclerosis Centers Annual Meeting • GlobeNewswire Inc. • 05/31/2024 11:30:00 AM
- TG Therapeutics Announces Schedule of Upcoming Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the 2024 Consortium of Multiple Sclerosis Centers Annual Meeting • GlobeNewswire Inc. • 05/28/2024 11:30:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/06/2024 08:59:11 PM
- TG Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results • GlobeNewswire Inc. • 05/01/2024 11:00:00 AM
- TG Therapeutics to Host Conference Call on First Quarter 2024 Financial Results and Business Update • GlobeNewswire Inc. • 04/30/2024 08:55:29 PM
- TG Therapeutics Announces Additional Data Presentations for BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting • GlobeNewswire Inc. • 04/18/2024 11:30:00 AM
- TG Therapeutics Awarded National Contract by the Department of Veterans Affairs for BRIUMVI as the Preferred Anti-CD20 for Relapsing Forms of Multiple Sclerosis • GlobeNewswire Inc. • 04/18/2024 11:00:00 AM
- TG Therapeutics Announces Presentation of Data for BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting • GlobeNewswire Inc. • 04/15/2024 11:30:00 AM
- TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting • GlobeNewswire Inc. • 03/08/2024 12:30:00 PM
- TG Therapeutics Announces Presentation of Data for BRIUMVI® in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum • GlobeNewswire Inc. • 03/01/2024 12:30:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/29/2024 10:23:27 PM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM